Physician profile
John Stewart
NPI 1851374383
$17,300.94
in general payments reported to CMS, 2019-2025
9 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,005 · 2021: $199 · 2023: $14K · 2024: $156 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Travel and Lodging: $2,523 · Food and Beverage: $1,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,321.93 |
| Travel and Lodging | $2,523.41 |
| Food and Beverage | $1,251.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $13,460.02 | 2023 | Stratafix, Harmonic, Echelon Flex |
| Boehringer Ingelheim International Gmbh | $3,190.00 | 2020-2021 | |
| Ethicon US, LLC | $250.66 | 2024-2025 | Echelon Flex, Vistaseal |
| Boston Scientific Corporation | $155.86 | 2023-2024 | Resonate El Icd Vr, Emblem Mri S-Icd, Watchman Access System |
| Regeneron Healthcare Solutions, INC. | $141.70 | 2023 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $58.31 | 2023 | |
| Aroa Biosurgery Incorporated | $30.57 | 2025 | |
| Daiichi Sankyo INC. | $13.82 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.